基于超声的预测模型评估眶内恶性肿瘤风险
研究纳入2017年1月至2023年4月共510例眶内占位患者,开发队列408例中基于超声及临床特征构建预测模型与列线图,验证队列102例中验证。模型鉴别恶性肿瘤的AUC为0.93,优于MRI的0.69及两名观察者的0.80与0.71;验证队列AUC为0.88。
要点
- 模型基于超过两个象限受累、形态不规则、实性部分极低回声、存在强回声灶、铸型样外观及年龄、性别构建。
- 开发队列中模型AUC 0.93(95%CI 0.90,0.95),优于MRI的0.69(95%CI 0.64,0.74)及两名观察者。
- 验证队列中模型AUC为0.88(95%CI 0.81,0.94)。
核心结论
- 基于超声及临床特征的预测模型能准确识别眶内恶性肿瘤,为临床实践提供便捷方法。
研究设计与样本
- 研究纳入510例眶内占位患者,分为开发队列408例和验证队列102例;开发队列中识别有鉴别价值的超声及临床特征并构建预测模型与列线图,比较模型与MRI或观察者的诊断性能,并在验证队列中验证。
关键影像表现/征象
- 超过两个象限受累、形态不规则、实性部分极低回声、存在强回声灶、铸型样外观及年龄和性别为与眶内恶性肿瘤相关的独立特征。
诊断标准与关键数值
- 开发队列中,模型识别恶性肿瘤的AUC为0.93(95%CI 0.90,0.95),MRI为0.69(95%CI 0.64,0.74),两者比较p=0.03。
- 开发队列中,模型AUC 0.93(95%CI 0.90,0.95) vs 观察者1 AUC 0.80(95%CI 0.76,0.84),p<0.01; vs 观察者2 AUC 0.71(95%CI 0.66,0.76),p<0.01。
- 验证队列中,模型AUC为0.88(95%CI 0.81,0.94)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Ultrasound (US) is widely used for evaluating various orbital conditions. However, accurately diagnosing malignant orbital masses using US remains challenging. We aimed to develop an ultrasonic feature-based model to predict the presence of malignant tumors in the orbit.
METHODS: A total of 510 patients with orbital masses were enrolled between January 2017 and April 2023. They were divided into a development cohort and a validation cohort. In the development cohort (n = 408), the ultrasonic and clinical features with differential values were identified. Based on these features, a predictive model and nomogram were constructed. The diagnostic performance of the model was compared with that of MRI or observers, and further validated in the validation cohort (n = 102).
RESULTS: The involvement of more than two quadrants, irregular shape, extremely low echo of the solid part, presence of echogenic foci, cast-like appearance, and two demographic characteristics (age and sex) were identified as independent features related to malignant tumors of the orbit. The predictive model constructed based on these features exhibited better performance in identifying malignant tumors compared to MRI (AUC = 0.78 [95% CI: 0.73, 0.82] vs. 0.69 [95% CI: 0.64, 0.74], p = 0.03) and observers (AUC = 0.93 [95% CI: 0.90, 0.95] vs. Observer 1, AUC = 0.80 [95% CI: 0.76, 0.84], p < 0.01; vs. Observer 2, AUC = 0.71 [95% CI: 0.66, 0.76], p < 0.01). In the validation cohort, the predictive model achieved an AUC of 0.88 (95% CI: 0.81, 0.94).
CONCLUSION: The ultrasonic-clinical feature-based predictive model can accurately identify malignant orbital tumors, offering a convenient approach in clinical practice.
引用
- Zhang Y, Huang Y, Bi J, et al. Ultrasound-Based Predictive Model to Assess the Risk of Orbital Malignancies. Ultrasound Med Biol. 2024. PMID: 38575417. doi:10.1016/j.ultrasmedbio.2024.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。